Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin

QR Code

Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin

Ying Cao,1,&ast; Yibei Dai,1,&ast; Lingyu Zhang,1 Danhua Wang,1 Wen Hu,2 Qiao Yu,3 Xuchu Wang,1 Pan Yu,1 Weiwei Liu,1 Ying Ping,1 Tao Sun,1 Yiwen Sang,1 Zhenping Liu,4 Yan Chen,3 Zhihua Tao1 1Department of Laboratory Medicine, Zhejiang University School of Medicine Second Affiliated Hospital...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Cao Y, Dai Y, Zhang L, Wang D, Hu W, Yu Q, Wang X, Yu P, Liu W, Ping Y, Sun T, Sang Y, Liu Z, Chen Y, Tao Z
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2021
Sujets:	inflammatory bowel disease fecal biomarkers oncostatin m calprotectin diagnosis activity infliximab response Pathology RB1-214 Therapeutics. Pharmacology RM1-950
Accès en ligne:	https://doaj.org/article/66e06f62a534404c901716fefdb9cf78
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Fecal calprotectin and microbiota of the gut
par: V. G. Gorokhova, et autres
Publié: (2016)

WNT16 is Robustly Increased by Oncostatin M in Mouse Calvarial Osteoblasts and Acts as a Negative Feedback Regulator of Osteoclast Formation Induced by Oncostatin M
par: Henning P, et autres
Publié: (2021)

Fecal microbiota transplant – a new frontier in inflammatory bowel disease
par: Sunkara T, et autres
Publié: (2018)

Improvement in Clinical Symptoms and Fecal Microbiome After Fecal Microbiota Transplantation in a Dog with Inflammatory Bowel Disease
par: Niina A, et autres
Publié: (2019)

Is Fecal Calprotectin an Applicable Biomarker of Gut Immune System Activation in Chronic Inflammatory Demyelinating Polyneuropathy? – A Pilot Study
par: Magdalena Koszewicz, et autres
Publié: (2021)

Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease
par: Sara Salvador-Martín, et autres
Publié: (2021)

Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
par: Azimirad M, et autres
Publié: (2020)

Dynamic Colonization of Microbes and Their Functions after Fecal Microbiota Transplantation for Inflammatory Bowel Disease
par: Nathaniel D. Chu, et autres
Publié: (2021)

Blood calprotectin in children with juvenile idiopathic arthritis: relationship to flare development after discontinuation of treatment
par: Yaryna Boyko, et autres
Publié: (2020)

Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction
par: Youlian Zhou, et autres
Publié: (2018)

Extraintestinal Manifestations and Intestinal Complications in Patients with Crohn's Disease: Associations with Some Clinico-Laboratory Findings, Immunological Markers and Therapy
par: Velikova Tsvetelina, et autres
Publié: (2018)

Management of fecal incontinence - focus on a vaginal insert for bowel control
par: Sokol ER
Publié: (2016)

Serum Calprotectin a Potential Biomarker in Juvenile Idiopathic Arthritis: A Meta-Analysis
par: Emma Altobelli, et autres
Publié: (2021)

The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
par: Xu X, et autres
Publié: (2021)

Systematic Metabolic Profiling of Mice with Dextran Sulfate Sodium-Induced Colitis
par: Xie D, et autres
Publié: (2021)

Application of Artificial Intelligence Modeling Technology Based on Multi-Omics in Noninvasive Diagnosis of Inflammatory Bowel Disease
par: Huang Q, et autres
Publié: (2021)

Recent Progress in the Diagnosis and Precise Nanocarrier-Mediated Therapy of Inflammatory Bowel Disease
par: Wang L, et autres
Publié: (2021)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
par: Xiufang Cui, et autres
Publié: (2021)

Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management – a follow-up study in a private inflammatory bowel disease center (2003–2017)
par: Cury DB, et autres
Publié: (2019)

Seminars in inflammatory bowel disease
Publié: (2001)

Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives
par: Rawla P, et autres
Publié: (2018)

Diagnostic and Prognostic Value of Immune/Inflammation Biomarkers for Venous Thromboembolism: Is It Reliable for Clinical Practice?
par: Xue J, et autres
Publié: (2021)

Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center
par: Gianluca Ianiro, et autres
Publié: (2021)

Association of tumor necrosis factor-α and -β gene polymorphisms in inflammatory bowel disease
par: Al-Meghaiseeb ES, et autres
Publié: (2016)

Dynamics of the Level of Myeloperoxidase and Serum Calprotectin in Local Cold Injury
par: M. I. Mikhailichenko, et autres
Publié: (2020)

Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn’s Disease Patients
par: Matthew K. Doherty, et autres
Publié: (2018)

The role of inflammation in irritable bowel syndrome (IBS)
par: Ng QX, et autres
Publié: (2018)

Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment—A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model
par: David Ternant, et autres
Publié: (2021)

Effects of crowding and sex on fecal cortisol levels of captive forest musk deer
par: He,Lan, et autres
Publié: (2014)

Selenium-Containing Amino Acids Protect Dextran Sulfate Sodium-Induced Colitis via Ameliorating Oxidative Stress and Intestinal Inflammation
par: Shi C, et autres
Publié: (2021)

The Flavonoid Kurarinone Regulates Macrophage Functions via Aryl Hydrocarbon Receptor and Alleviates Intestinal Inflammation in Irritable Bowel Syndrome
par: Xu X, et autres
Publié: (2021)

Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management
par: Igor G. Bakulin, et autres
Publié: (2021)

Multifocal colorectal non-Hodgkin's lymphoma in a patient with ulcerative colitis: A case report
par: Sagar Walinjkar, et autres
Publié: (2021)

Integrated Gene Expression Profiling Analysis Reveals Probable Molecular Mechanism and Candidate Biomarker in Anti-TNFα Non-Response IBD Patients
par: Liu Y, et autres
Publié: (2020)

Editorial: Game Changers in Inflammatory Bowel Diseases
par: Anita Bálint, et autres
Publié: (2021)

Enhancement of Circulating and Intestinal T Regulatory Cells and Their Expression of Helios and Neuropilin-1 in Children with Inflammatory Bowel Disease
par: Sznurkowska K, et autres
Publié: (2020)

Biomarcadores en enfermedad inflamatoria intestinal: ¿sabe cómo utilizarlos?
par: Pérez de Arce,Edith, et autres
Publié: (2020)

Ulcerative colitis relapse after Helicobacter pylori eradication in a 12-year-old boy with duodenal ulcer
par: Yuji Fujita, et autres
Publié: (2021)

Research on Correlation Between Psychological Factors, Mast Cells, and PAR-2 Signal Pathway in Irritable Bowel syndrome
par: Chao G, et autres
Publié: (2021)

Gut Microbiota Contributes to Host Defense Against Klebsiella pneumoniae-Induced Liver Abscess
par: Zheng Y, et autres
Publié: (2021)